Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $CVKD
Cadrenal Therapeutics Inc.
Subscribe to $CVKD
$CVKD
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2023
Exchange: NASDAQ
Recent Analyst Ratings for Cadrenal Therapeutics Inc.
Date
Price Target
Rating
Analyst
12/18/2023
$4.00
Outperform
Noble Capital Markets
See more ratings
